Metformin 500mg (DrugBank: Metformin)
21 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
2 | 筋萎縮性側索硬化症 | 0 |
6 | パーキンソン病 | 0 |
13 | 多発性硬化症/視神経脊髄炎 | 0 |
46 | 悪性関節リウマチ | 0 |
49 | 全身性エリテマトーデス | 0 |
60 | 再生不良性貧血 | 0 |
67 | 多発性嚢胞腎 | 0 |
75 | クッシング病 | 0 |
77 | 下垂体性成長ホルモン分泌亢進症 | 0 |
81 | 先天性副腎皮質酵素欠損症 | 0 |
86 | 肺動脈性肺高血圧症 | 0 |
113 | 筋ジストロフィー | 1 |
127 | 前頭側頭葉変性症 | 0 |
158 | 結節性硬化症 | 0 |
206 | 脆弱X症候群 | 0 |
225 | 先天性腎性尿崩症 | 0 |
233 | ウォルフラム症候群 | 0 |
265 | 脂肪萎縮症 | 0 |
285 | ファンコニ貧血 | 0 |
299 | 嚢胞性線維症 | 0 |
301 | 黄斑ジストロフィー | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | EUCTR2013-001732-21-FR (EUCTR) | 06/09/2013 | 18/02/2014 | A phase II study of metformin in myotonic dystrophy type 1 patients | A randomized, double blind, placebo-controlled phase II study of metformin in myotonic dystrophy type 1 patients - Myomet | Myotonic dystrophy type 1 (DM1) also known as Steinert disease;Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05] | Trade Name: metformin 500mg INN or Proposed INN: METFORMIN | Centre d'Etude des Cellules Souches (CECS) | NULL | Not Recruiting | Female: yes Male: yes | 30 | Phase 2 | France |